Among the most significantly affected top 10 DEGs, CD36 and IGFBP2 are highly associated with MASLD development (Hedbacker et al, 2010; Wilson et al, 2016) (Fig. 4A,B). Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.